Invesco’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.41B | Buy |
4,817,410
+913,532
| +23% | +$300M | 0.14% | 121 |
|
|
2025
Q4 | $1.37B | Buy |
3,903,878
+1,306,390
| +50% | +$441M | 0.13% | 127 |
|
|
2025
Q3 | $839M | Buy |
2,597,488
+484,303
| +23% | +$151M | 0.13% | 156 |
|
|
2025
Q2 | $822M | Sell |
2,113,185
-3,104
| -0.1% | -$1.25M | 0.14% | 152 |
|
|
2025
Q1 | $921M | Buy |
2,116,289
+24,833
| +1% | +$9.97M | 0.17% | 114 |
|
|
2024
Q4 | $772M | Sell |
2,091,456
-290,352
| -12% | -$122M | 0.14% | 147 |
|
|
2024
Q3 | $1.24B | Buy |
2,381,808
+551,585
| +30% | +$295M | 0.24% | 66 |
|
|
2024
Q2 | $992M | Sell |
1,830,223
-207,037
| -10% | -$109M | 0.21% | 84 |
|
|
2024
Q1 | $1.06B | Buy |
2,037,260
+101,406
| +5% | +$50.4M | 0.23% | 70 |
|
|
2023
Q4 | $913M | Buy |
1,935,854
+80,324
| +4% | +$37.1M | 0.22% | 83 |
|
|
2023
Q3 | $808M | Buy |
1,855,530
+54,877
| +3% | +$24.9M | 0.22% | 79 |
|
|
2023
Q2 | $800M | Sell |
1,800,653
-189,335
| -10% | -$87.3M | 0.21% | 92 |
|
|
2023
Q1 | $915M | Sell |
1,989,988
-411,268
| -17% | -$196M | 0.26% | 68 |
|
|
2022
Q4 | $1.23B | Sell |
2,401,256
-422,994
| -15% | -$215M | 0.36% | 36 |
|
|
2022
Q3 | $1.28B | Sell |
2,824,250
-236,578
| -8% | -$113M | 0.41% | 24 |
|
|
2022
Q2 | $1.48B | Buy |
3,060,828
+100,655
| +3% | +$49.8M | 0.45% | 25 |
|
|
2022
Q1 | $1.45B | Buy |
2,960,173
+28,289
| +1% | +$12.9M | 0.37% | 32 |
|
|
2021
Q4 | $1.36B | Sell |
2,931,884
-23,426
| -0.8% | -$9.86M | 0.33% | 46 |
|
|
2021
Q3 | $1.1B | Buy |
2,955,310
+671,275
| +29% | +$255M | 0.28% | 60 |
|
|
2021
Q2 | $872M | Sell |
2,284,035
-162,937
| -7% | -$62.3M | 0.21% | 85 |
|
|
2021
Q1 | $878M | Sell |
2,446,972
-791,210
| -24% | -$254M | 0.23% | 72 |
|
|
2020
Q4 | $1.04B | Sell |
3,238,182
-760,372
| -19% | -$233M | 0.3% | 47 |
|
|
2020
Q3 | $1.07B | Sell |
3,998,554
-669,440
| -14% | -$180M | 0.36% | 35 |
|
|
2020
Q2 | $1.23B | Sell |
4,667,994
-200,263
| -4% | -$53.4M | 0.44% | 29 |
|
|
2020
Q1 | $1.11B | Sell |
4,868,257
-825,643
| -15% | -$225M | 0.47% | 26 |
|
|
2019
Q4 | $1.72B | Sell |
5,693,900
-3,561
| -0.1% | -$980K | 0.53% | 16 |
|
|
2019
Q3 | $1.37B | Buy |
5,697,461
+29,681
| +0.5% | +$8.13M | 0.36% | 41 |
|
|
2019
Q2 | $1.6B | Buy |
5,667,780
+2,204,247
| +64% | +$602M | 0.41% | 27 |
|
|
2019
Q1 | $994M | Sell |
3,463,533
-19,178
| -0.6% | -$5.55M | 0.34% | 45 |
|
|
2018
Q4 | $915M | Sell |
3,482,711
-273,806
| -7% | -$75.3M | 0.35% | 44 |
|
|
2018
Q3 | $1.03B | Sell |
3,756,517
-165,258
| -4% | -$42.9M | 0.32% | 56 |
|
|
2018
Q2 | $934M | Buy |
3,921,775
+46,454
| +1% | +$10.8M | 0.31% | 58 |
|
|
2018
Q1 | $851M | Sell |
3,875,321
-69,949
| -2% | -$16.4M | 0.32% | 56 |
|
|
2017
Q4 | $888M | Sell |
3,945,270
-219,001
| -5% | -$46.6M | 0.32% | 60 |
|
|
2017
Q3 | $791M | Sell |
4,164,271
-83,353
| -2% | -$15.9M | 0.29% | 66 |
|
|
2017
Q2 | $799M | Buy |
4,247,624
+197,929
| +5% | +$35.6M | 0.25% | 76 |
|
|
2017
Q1 | $670M | Sell |
4,049,695
-61,130
| -1% | -$9.72M | 0.22% | 91 |
|
|
2016
Q4 | $591M | Buy |
4,110,825
+49,535
| +1% | +$6.63M | 0.2% | 107 |
|
|
2016
Q3 | $509M | Sell |
4,061,290
-28,400
| -0.7% | -$3.67M | 0.17% | 123 |
|
|
2016
Q2 | $537M | Buy |
4,089,690
+97,308
| +2% | +$13.3M | 0.2% | 106 |
|
|
2016
Q1 | $555M | Sell |
3,992,382
-128,391
| -3% | -$17.2M | 0.23% | 93 |
|
|
2015
Q4 | $575M | Sell |
4,120,773
-305,340
| -7% | -$42.1M | 0.23% | 89 |
|
|
2015
Q3 | $620M | Sell |
4,426,113
-727,297
| -14% | -$109M | 0.26% | 70 |
|
|
2015
Q2 | $846M | Sell |
5,153,410
-1,047,095
| -17% | -$167M | 0.33% | 44 |
|
|
2015
Q1 | $957M | Sell |
6,200,505
-294,145
| -5% | -$41.9M | 0.37% | 38 |
|
|
2014
Q4 | $816M | Sell |
6,494,650
-910,929
| -12% | -$113M | 0.32% | 52 |
|
|
2014
Q3 | $886M | Buy |
7,405,579
+155,839
| +2% | +$17.9M | 0.35% | 45 |
|
|
2014
Q2 | $780M | Buy |
7,249,740
+16,529
| +0.2% | +$1.7M | 0.31% | 56 |
|
|
2014
Q1 | $720M | Sell |
7,233,211
-667,190
| -8% | -$60.3M | 0.29% | 58 |
|
|
2013
Q4 | $730M | Sell |
7,900,401
-1,403,675
| -15% | -$125M | 0.29% | 58 |
|
|
2013
Q3 | $778M | Sell |
9,304,076
-106,888
| -1% | -$9.16M | 0.34% | 53 |
|
|
2013
Q2 | $770M | Buy |
+9,410,964
| New | +$704M | 0.36% | 44 |
|
Other funds holding ELV
VCM
VPM
Invesco's ELV Position: Q1 2026 in Review
Invesco increased its Elevance Health (ELV) stake by 23% in Q1 2026, buying an estimated $300M and bringing the position to 4,817,410 shares worth $1.41B. The position accounts for 0.14% of the portfolio, ranked #121.
Invesco first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.72B in Q4 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Invesco held 4,817,410 shares of Elevance Health worth $1.41B as of Q1 2026.
- Invesco bought 913,532 Elevance Health shares in Q1 2026, an estimated $300M.
- Elevance Health made up 0.14% of Invesco's portfolio in Q1 2026, its #121 holding.
- Invesco first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Invesco's Elevance Health position peaked at $1.72B in Q4 2019.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.